Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
article
OA: closed
CC0
⤵ 183 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized, placebo-controlled, double-blind study evaluated Lupron depot (leuprolide acetate for depot suspension) for the treatment of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- Luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W6607058909 via openalex
- W1957397409 via openalex
- W2129449855 via openalex
- W2150169562 via openalex
- W2297593361 via openalex
- W2394740139 via openalex
- W2408619637 via openalex
- W2477008945 via openalex
Cited by (50)
- Use of gonadotropic releasing hormone agonists in hyperplastic syndrome in gynecology 2025
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study 2023
- GnRH agonists in the treatment of symptomatic endometriosis: a review 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids 2022
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Endometriosis 2021
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials 2020
- Medical treatment of endometriosis: is it a choice of the physician? 2020
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
- Medical Management of Endometriosis in Adolescents 2020
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Chronic pelvic pain and endometriosis 2019
- Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain 2018
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- RETIRED: No. 164-Consensus Guidelines for the Management of Chronic Pelvic Pain 2018
- Current and emerging treatment options for endometriosis 2018
- RETIRED: No 164 - Directive clinique de consensus pour la prise en charge de la douleur pelvienne chronique 2018
- Management of Chronic Pelvic Pain 2017
- Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats 2017
- Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis 2016
- Endometriosis 2015
- On-label and off-label drug use in the treatment of endometriosis 2015
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial 2015
- Treatment of pelvic pain associated with endometriosis: a committee opinion 2014
- Medical Treatment of Ureteral Obstruction Associated With Ovarian Remnants and/or Endometriosis: Report of Three Cases and Review of the Literature 2014
- Epigenetics in Endometriosis 2014
- Ovarian hormones and chronic pain: A comprehensive review 2014
- The Place of Gonadotropin-Releasing Hormone Agonists in the Management of Endometriosis 2014
- Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study 2013
- Pelvic and Extragenital Endometriosis: A Review of the Surgical Management of Deeply Infiltrating Lesions 2013
- Epigenetic aberration of gene expression in endometriosis 2013
- Medical Treatment in Endometriosis 2012
- Effects of laparoscopic radical surgery for deep endometriosis on endometriosis-related pelvic pain 2012
- Towards gene therapy of endometriosis 2012
- Endometriosis 2012
- Gonadotropin releasing hormone agonists: Expanding vistas 2011
- CA 125 Modifications Throughout Menstrual Cycle and following GnRH-Analog Administration to Diagnose Endometriosis as Cause of Chronic Pelvic Pain. A Prospective Controlled Study 2011
- Endometriosis in the Adolescent Patient 2011
- Innovations in conservative endometriosis treatment: an updated review. 2011
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Endometriosis and the Adolescent 2010
- PPAR–gamma: a dagger in endometriosis 2010
- Endometriosis 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:05.481982+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK